Genmab
Company ● Covered in 1 story + Follow ✴ AI Graph
This profile is built automatically from TLDRocket coverage.
Signals
—
Media momentum
As of 4 Sep 2026 · Visible stories in the last 30 days, compared with the 30 days before.
1 source
Source diversity
As of 4 Sep 2026 · Distinct publications behind this entity's visible coverage.
—
Release activity
As of 4 Sep 2026 · Model, product and open-source release events in the last 90 days whose coverage involves this entity.
—
Funding signals
As of 4 Sep 2026 · Funding and acquisition events in the last 90 days whose coverage involves this entity.
Sep 2024
Coverage span
As of 4 Sep 2026 · First to most recent month of TLDRocket coverage of this entity.
Management
updated 5 Aug 2026- Jan G. J. van de Winkel President & CEO
- Jacob Brogaard-Kay Vice President, Global Talent & Culture
- Dan Zebrowski Vp, Commercialization Operations & Effectiveness
- Anthony Pagano EVP & CFO
- Peter Louwagie Senior Vice President Of Corporate Development/m&a & Bd&l
- Birgitte Stephensen Executive Vice President & Chief Legal Officer
- Judith Klimovsky Chief Development Officer
- Tahamtan Ahmadi CMO & Head, Experimental Medicines
- Leslie C Amendola Senior Vice President, US General Manager
- Rayne Waller EVP & Chief Technical Operations Officer
- John Keating Senior Vice President, Global Commercialization
- Bradley Bailey Executive Vice President & Chief Commercial Officer
+ 14 more tracked
Latest developments
2024
Relationships
Products & technology
- Deploys ChatGPT Enterprise · 1 source